Puglisi-Allegra S, Cabib S, Cestari V, Castellano C
Dipartimento di Psicologia Università di Roma La Sapienza, Italy.
Psychopharmacology (Berl). 1994 Jan;113(3-4):476-80. doi: 10.1007/BF02245226.
Post-training administration of minaprine (2.5, 5 and 10 mg/kg) dose-dependently improved retention of an inhibitory avoidance response in mice. Animals receiving nine daily injections of 5 mg/kg and administered a challenge dose post-training showed an improvement in memory consolidation similar to that produced by acute injection of 10 mg/kg. The effects on retention performance induced by the drug appear to be due to an effect on memory consolidation. They were observed when drugs were given at short, but not long, periods of time after training, i.e. when the memory trace was susceptible to modulation. Moreover, these effects are not to be ascribed to an aversive or a rewarding or non-specific action of the drugs on retention performance, as the latencies during the retention test of those mice that had not received a footshock during training were not affected by post-training drug administration. The effects of an acutely injected dose (10 mg/kg) of minaprine as well as those of a challenge dose (5 mg/kg) of the drug administered to repeatedly treated animals were reversed by pretreatment with either selective D1 or D2 dopamine receptor antagonists SCH 23390 and (-)-sulpiride administered at per se non-effective doses (0.025 and 6 mg/kg, respectively), thus suggesting that D1 and D2 receptor types are similarly involved in the effects of minaprine on memory consolidation. These results show that minaprine improves memory consolidation and that repeated drug administration leads to potentiation of this effect. Moreover, the effects of minaprine on memory consolidation are related to its dopaminergic action.
训练后给予米那普明(2.5、5和10毫克/千克)可剂量依赖性地改善小鼠抑制性回避反应的记忆保持。每天接受9次5毫克/千克注射并在训练后给予激发剂量的动物,其记忆巩固得到改善,类似于急性注射10毫克/千克所产生的效果。药物对记忆保持性能的影响似乎是由于对记忆巩固的作用。当在训练后的短时间而非长时间给予药物时可观察到这些影响,即当记忆痕迹易于调节时。此外,这些影响不应归因于药物对记忆保持性能的厌恶、奖赏或非特异性作用,因为在训练期间未接受足部电击的小鼠在记忆保持测试期间的潜伏期不受训练后药物给药的影响。急性注射剂量(10毫克/千克)的米那普明以及给予反复治疗动物的激发剂量(5毫克/千克)的药物作用,可被分别以本身无效剂量(分别为0.025和6毫克/千克)给予的选择性D1或D2多巴胺受体拮抗剂SCH 23390和(-)-舒必利预处理所逆转,因此表明D1和D2受体类型同样参与米那普明对记忆巩固的作用。这些结果表明,米那普明可改善记忆巩固,且重复给药会增强这种作用。此外,米那普明对记忆巩固的作用与其多巴胺能作用有关。